Common Antibiotics for Sinus Infections: When They Are—and Aren’t—Needed

When a sinus infection may be bacterial

Distinguishing between a viral infection and a bacterial one relies on the pattern and timeline of symptoms rather than any single finding. Green or yellow mucus, facial pressure, and nasal congestion are common in viral sinusitis and do not prove a bacterial cause. According to clinical guidelines, acute bacterial rhinosinusitis may be diagnosed when symptoms follow one of three specific patterns:

1. Persistent symptoms: Symptoms last for at least 10 days without any improvement.
2. Severe onset: Symptoms are severe from the start, including a fever of at least 39°C (102°F) accompanied by purulent nasal discharge or facial pain. This severe pattern typically persists for more than 3 to 4 consecutive days at the beginning of the illness.
3. Worsening after improvement: Also known as “double sickening,” this occurs when initial symptoms improve, but then fever, headache, or nasal discharge worsen again.

These criteria help clinicians determine whether the infection has likely progressed to a bacterial cause that might require antibiotic intervention. Keep this focus on acute disease. Chronic rhinosinusitis is defined by symptoms lasting 12 weeks or longer and follows a different clinical pathway. Chronic symptoms should not be treated as simply prolonged acute bacterial sinusitis; they require a separate, more comprehensive evaluation to address underlying structural or inflammatory issues rather than assuming immediate bacterial infection.

First-line antibiotics and how clinicians choose

Amoxicillin-clavulanate is commonly selected as first-line therapy because the clavulanate component inhibits beta-lactamase enzymes produced by common sinus pathogens, which would otherwise resist amoxicillin alone. The Infectious Diseases Society of America (IDSA) guideline specifically recommends amoxicillin-clavulanate over amoxicillin monotherapy for empiric treatment. The American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) guideline allows for amoxicillin with or without clavulanate, reflecting some variation in clinical preference.

The final choice of antibiotic depends heavily on patient-specific factors that a clinician must evaluate. Key considerations include:

• Allergy history: A documented penicillin allergy rules out first-line beta-lactam options.
• Recent antibiotic exposure: Recent use of antibiotics may influence the choice if resistance is a concern.
• Illness severity: The presence of high fever or severe pain may influence the initial drug selection.
• Local resistance patterns: Regional differences in bacterial resistance can guide empiric choices.
• Patient physiology: Age, pregnancy status, kidney function, and other comorbidities affect safety and dosing.

Clinicians do not select antibiotics in a vacuum. The prescription is tailored to the individual's medical history to maximize effectiveness and minimize risk. Self-selection of antibiotics, sharing medication, or using leftover prescriptions from previous illnesses is unsafe and ineffective, as it ignores these critical personal factors.

Alternatives for penicillin allergy or treatment failure

When an adult patient cannot take penicillin-based antibiotics, clinicians must select alternative agents that are effective against common sinus pathogens. For adults with a penicillin allergy, the IDSA guideline lists doxycycline as a guideline-supported alternative. Respiratory fluoroquinolones, such as levofloxacin or moxifloxacin, are also listed as options for penicillin-allergic adults.

Fluoroquinolones are not casual substitutes. Due to their potential for serious side effects and the goal of preserving their utility for more resistant infections, their use requires careful clinician review of patient-specific risks. They are generally reserved for cases where other options are not feasible or appropriate.

Note what is not recommended. The IDSA guideline explicitly advises against using macrolides, such as azithromycin or clarithromycin, or trimethoprim-sulfamethoxazole, for empiric treatment of acute bacterial rhinosinusitis. This is due to high rates of resistance among the common pathogens that cause sinus infections. Prescribing these agents often results in treatment failure because the bacteria are no longer susceptible to them.

If a patient starts on an empiric antibiotic and fails to improve, the issue is not simply that the first drug was wrong. Treatment failure warrants reassessment to check for resistant pathogens, structural abnormalities, or noninfectious causes. Switching antibiotics without clinical guidance can lead to further resistance or missed diagnoses. Alternative treatments for pediatric patients or pregnant individuals require separate, specialized clinical decisions and should not be inferred from adult guidelines.

How long treatment lasts and when improvement is expected

For uncomplicated acute bacterial rhinosinusitis in adults, the IDSA guideline recommends a treatment duration of 5 to 7 days. This shorter course is considered sufficient for most patients and helps reduce the risk of side effects and antibiotic resistance compared to longer traditional regimens. This duration is a general guideline; the exact length of treatment should be determined by a clinician based on the individual's response and severity.

Improvement is generally expected within a few days of starting effective antibiotic therapy. The timeline for reassessment is critical. If a patient's symptoms worsen after 48 to 72 hours of treatment, or if there is no improvement after 3 to 5 days of initial empiric therapy, the patient should be reassessed by a clinician.

Reassessment at this stage allows the provider to investigate why the treatment is not working. Possible reasons include infection with a resistant organism, a noninfectious cause of the symptoms, a structural abnormality in the sinuses, or a completely different diagnosis. Patients should not extend, shorten, stop, or replace a prescribed course of antibiotics on their own. Doing so can lead to incomplete treatment, recurrence of the infection, or increased resistance. Always consult the prescriber before making any changes to the medication regimen.

Side effects, resistance, and medication precautions

Antibiotic use carries inherent risks, and unnecessary use exposes patients to adverse effects without providing clinical benefit. Since most sinus infections are viral, antibiotics do not help and only add risk. These risks include common side effects such as gastrointestinal distress, as well as more serious potential complications.

Specific precautions apply to first-line agents like amoxicillin-clavulanate. US labeling contraindicates this medication in patients with a history of serious hypersensitivity reactions to beta-lactam antibiotics. It is also contraindicated in individuals with previous cholestatic jaundice or hepatic dysfunction associated with amoxicillin-clavulanate. Patients must disclose any history of liver issues or severe allergic reactions to their healthcare provider.

Before starting any antibiotic, patients should review their complete medical profile with their prescriber or pharmacist. This includes:

• Allergies: Any known drug allergies, especially to penicillin or cephalosporins.
• Pregnancy and breastfeeding: To ensure safety for both the patient and the infant.
• Organ function: Kidney or liver problems can affect how the body processes and eliminates the drug.
• Current medications: To check for potential interactions that could alter the effectiveness of the antibiotic or cause adverse effects.

Never assume a medication is safe based on general information. Individual factors dictate safety, and a healthcare professional is the only one who can provide personalized guidance.

When to contact a clinician again

Clinical assessment is necessary before starting an antibiotic if the symptom patterns suggesting bacterial infection are present, or if the diagnosis itself is uncertain. Because antibiotics are not appropriate for viral infections, confirming the need for them requires professional evaluation.

Reassessment is crucial during treatment. Patients should contact their clinician if:

• Symptoms worsen within 48 to 72 hours of starting antibiotics.
• There is no improvement after 3 to 5 days of empiric treatment.
• Symptoms recur after initial improvement.
• Symptoms persist for 12 weeks or longer, which indicates chronic rhinosinusitis and requires a different diagnostic approach.

Suspected complications, such as severe headaches, vision changes, or high persistent fever, require prompt in-person evaluation to rule out serious conditions. Do not attempt to manage worsening or prolonged symptoms with leftover medications or self-adjusted dosing. Always seek professional medical advice to ensure proper diagnosis and safe treatment.